Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Management of Left Ventricular Thrombus

Diagnostic Approach

  • The American College of Cardiology recommends transesophageal echocardiography (TEE) as the preferred imaging modality to visualize LV thrombus, including its size, location, and mobility 2

Treatment Algorithm

  • The American College of Cardiology recommends beginning immediate anticoagulation with intravenous unfractionated heparin (target aPTT >2 times control) for patients with confirmed LV thrombus 2
  • The American Heart Association recommends transitioning to oral anticoagulation with warfarin (target INR 2.5-3.5) for patients with confirmed LV thrombus 1
  • The American College of Cardiology recommends adding low-dose aspirin (81-100 mg/day) if no contraindications exist for patients with confirmed LV thrombus 2
  • The American Heart Association recommends continuing anticoagulation for a minimum of 3 months for patients with confirmed LV thrombus 1
  • The American College of Cardiology recommends considering extended therapy in patients with large or mobile thrombi 2

Special Situations

  • The American College of Cardiology recommends considering thrombolytic therapy followed by heparin, then warfarin plus aspirin for high surgical risk patients (NYHA class III-IV) with prosthetic valve thrombosis 2
  • The American Heart Association recommends warfarin for at least 3 months for patients with ischemic stroke or TIA and LV thrombus 1

Follow-up

  • The American College of Cardiology recommends performing serial echocardiography every 1-3 months to assess for thrombus resolution 2
  • The American College of Cardiology recommends considering surgical intervention if thrombus persists despite adequate anticoagulation after 3-6 months 2

Emerging Evidence on Direct Oral Anticoagulants (DOACs)

  • The American Heart Association found that one study comparing DOACs to warfarin found higher rates of stroke or systemic embolism in the DOAC group 1

Common Pitfalls and Caveats

  • The American College of Cardiology found that inadequate anticoagulation intensity (subtherapeutic INR) is associated with treatment failure and increased thromboembolic risk 2